MTOR and skin cancer: Reduces the changes in phosphorylated levels of PI3K, AKT, mTOR and AMPK while decreasing p38 phosphorylation; inhibits proliferation; and induces apoptosis and autophagy. It may have a therapeutic value in the chemoprophylaxis of skin cancer.